Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea
· Delayed Price · Currency is KRW 5,640.00
-30.00 (-0.53%)
At close: Mar 25, 2025, 3:30 PM KST
Kyung Dong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 5,470 | -20,708 | 12,161 | 12,672 | 12,459 | Upgrade
|
| Depreciation & Amortization | 5,420 | 5,849 | 6,704 | 7,011 | 6,774 | Upgrade
|
| Loss (Gain) From Sale of Assets | -92.39 | -61.03 | 142.27 | -73.22 | -24.37 | Upgrade
|
| Asset Writedown & Restructuring Costs | 197.41 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,765 | -2,149 | 1,709 | -786.97 | 97.44 | Upgrade
|
| Loss (Gain) on Equity Investments | -503.27 | -3,083 | -11,387 | 155.57 | 100.42 | Upgrade
|
| Provision & Write-off of Bad Debts | -900.68 | 1,577 | 64.7 | 66 | -2,258 | Upgrade
|
| Other Operating Activities | -6,016 | -236.45 | 4,218 | -2,090 | 2,950 | Upgrade
|
| Change in Accounts Receivable | -2,816 | 4,146 | -3,855 | -3,561 | 2,201 | Upgrade
|
| Change in Inventory | -7,837 | -4,494 | -2,619 | -636.73 | -4,738 | Upgrade
|
| Change in Accounts Payable | 123.61 | -776.13 | -92.64 | 1,873 | -2,263 | Upgrade
|
| Change in Other Net Operating Assets | 646.2 | 19,904 | -8,119 | -2,207 | 1,818 | Upgrade
|
| Operating Cash Flow | -8,074 | -31.94 | -1,075 | 12,422 | 17,116 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -27.42% | - | Upgrade
|
| Capital Expenditures | -7,618 | -6,290 | -10,574 | -3,926 | -28,591 | Upgrade
|
| Sale of Property, Plant & Equipment | 993.5 | 344.32 | 126.36 | 222.18 | 42.39 | Upgrade
|
| Sale (Purchase) of Intangibles | -3,792 | -1,677 | 161.82 | -811.28 | 230.75 | Upgrade
|
| Investment in Securities | 10,513 | 22,985 | -3,749 | 12,145 | -23,530 | Upgrade
|
| Other Investing Activities | 2,168 | 3,301 | 1,449 | 2,786 | 2,523 | Upgrade
|
| Investing Cash Flow | 2,264 | 18,664 | -12,585 | 10,713 | -49,624 | Upgrade
|
| Short-Term Debt Issued | 162,522 | 110,594 | 68,182 | - | 617.8 | Upgrade
|
| Total Debt Issued | 162,522 | 110,594 | 68,182 | - | 617.8 | Upgrade
|
| Short-Term Debt Repaid | -138,897 | -119,663 | -44,251 | -481.93 | - | Upgrade
|
| Long-Term Debt Repaid | -148.88 | -573.83 | -1,595 | -1,534 | -1,381 | Upgrade
|
| Total Debt Repaid | -139,046 | -120,237 | -45,846 | -2,016 | -1,381 | Upgrade
|
| Net Debt Issued (Repaid) | 23,476 | -9,643 | 22,336 | -2,016 | -763.02 | Upgrade
|
| Repurchase of Common Stock | -1,280 | - | -750.51 | -5,517 | -1,464 | Upgrade
|
| Dividends Paid | -10,854 | -10,854 | -10,894 | -13,834 | -11,821 | Upgrade
|
| Other Financing Activities | -1,729 | -921.28 | -304.11 | -106.26 | -23.15 | Upgrade
|
| Financing Cash Flow | 9,613 | -21,418 | 10,388 | -21,474 | -14,070 | Upgrade
|
| Foreign Exchange Rate Adjustments | 186.58 | 11.75 | 17.78 | 153.47 | -383.18 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | 3,990 | -2,774 | -3,254 | 1,815 | -46,961 | Upgrade
|
| Free Cash Flow | -15,692 | -6,322 | -11,649 | 8,496 | -11,475 | Upgrade
|
| Free Cash Flow Margin | -8.09% | -3.89% | -6.38% | 4.78% | -6.60% | Upgrade
|
| Free Cash Flow Per Share | -582.38 | -232.93 | -428.12 | 308.70 | -467.69 | Upgrade
|
| Cash Interest Paid | 1,769 | 921.28 | 244.11 | 6.26 | 3.01 | Upgrade
|
| Cash Income Tax Paid | 4,777 | 2,796 | 5,692 | 8,698 | 8,633 | Upgrade
|
| Levered Free Cash Flow | -22,117 | 510.19 | -2,773 | 6,388 | -7,607 | Upgrade
|
| Unlevered Free Cash Flow | -20,767 | 1,508 | -2,231 | 6,429 | -6,836 | Upgrade
|
| Change in Net Working Capital | 16,417 | -19,222 | 3,718 | 5,694 | -2,435 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.